Literature DB >> 9668064

Purification and characterization of a protein binding to the SP6 kappa promoter. A potential role for CArG-box binding factor-A in kappa transcription.

M Bemark1, H Olsson, D Heinegård, T Leanderson.   

Abstract

A protein interacting with an A-T-rich region that is a positive control element within the SP6 kappa promoter was purified and identified as CArG-box binding factor-A. The purified protein was shown to interact specifically with the coding strand of single-stranded DNA and, with lower affinity, with double-stranded DNA. A mutation that inhibited binding of the protein to the A-T-rich region also aborted the transcriptional stimulatory effect of the region. Two Ets proteins, PU.1 and elf-1, that have previously been shown to bind to an adjacent DNA element were shown to physically interact with CArG-box binding factor-A. An antiserum raised against the protein recognized two different forms indicating either that different splice-forms of CArG-box binding factor-A are expressed, or that the protein is subject to post-translational modification.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668064     DOI: 10.1074/jbc.273.30.18881

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins.

Authors:  Piergiorgio Percipalle; Andreas Jonsson; Dmitri Nashchekin; Christina Karlsson; Tomas Bergman; Apostolia Guialis; Bertil Daneholt
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

2.  Destabilization of tetraplex structures of the fragile X repeat sequence (CGG)n is mediated by homolog-conserved domains in three members of the hnRNP family.

Authors:  Samer Khateb; Pnina Weisman-Shomer; Inbal Hershco; Lawrence A Loeb; Michael Fry
Journal:  Nucleic Acids Res       Date:  2004-08-09       Impact factor: 16.971

3.  A proximal activator of transcription in epithelial-mesenchymal transition.

Authors:  Christo D Venkov; Andrew J Link; Jennifer L Jennings; David Plieth; Tsutomu Inoue; Kojiro Nagai; Carol Xu; Yoana N Dimitrova; Frank J Rauscher; Eric G Neilson
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

4.  Transcriptional regulation of epithelial-mesenchymal transition.

Authors:  Yingqi Teng; Michael Zeisberg; Raghu Kalluri
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

5.  In-vitro dual binding activity of a evolutionarily related subgroup of hnRNP proteins.

Authors:  Antonella Bandiera; Nevenka Medic; A Akintunde Akindahunsi; Giorgio Manzini
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

6.  Identification of S1 proteins B2, C1 and D1 as AUF1 isoforms and their major role as heterogeneous nuclear ribonucleoprotein proteins.

Authors:  Akira Inoue; Yukitomo Arao; Akira Omori; Sachiyo Ichinose; Koji Nishio; Naoki Yamamoto; Yosihiro Kinoshita; Shiro Mita
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

7.  Hnrpab regulates neural development and neuron cell survival after glutamate stimulation.

Authors:  John R Sinnamon; Catherine B Waddell; Sara Nik; Emily I Chen; Kevin Czaplinski
Journal:  RNA       Date:  2012-02-13       Impact factor: 4.942

8.  Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis.

Authors:  Stephanie T Shi; Guann-Yi Yu; Michael M C Lai
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Distinct domains in the CArG-box binding factor A destabilize tetraplex forms of the fragile X expanded sequence d(CGG)n.

Authors:  Pnina Weisman-Shomer; Esther Cohen; Michael Fry
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

10.  In cultured oligodendrocytes the A/B-type hnRNP CBF-A accompanies MBP mRNA bound to mRNA trafficking sequences.

Authors:  Chandrasekhar S Raju; Christian Göritz; Ylva Nord; Ola Hermanson; Carmen López-Iglesias; Neus Visa; Goncalo Castelo-Branco; Piergiorgio Percipalle
Journal:  Mol Biol Cell       Date:  2008-05-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.